Table 3 Rank scores of consensus statements for views on the different modalities of cutaneous leishmaniasis treatment

22

Sodium stibogluconate is the first drug of choice for the treatment of CL^a

23

Some patients do not benefit from intralesional sodium stibogluconate injection, even if many regular sessions are done^a

24

Cryotherapy with liquid nitrogen is one of alternative therapy to sodium stibogluconate in the treatment of CL^a

25

Cryotherapy with liquid nitrogen is better to be avoided in CL wet and ulcerated lesions^a

26

Children suffering from CL are still a dilemma for available treatment modalities^a

27

Majority of cases of CL are chronic since the morbidity last more up to and more than one year^a

28

Most of the cases of CL get complete healing within 4–6 months of treatment, and rarely they extend more than one year^a

29

Hypertonic saline intralesionally is of effective in the treatment of CL^a

30

Relapses are very common after CL treatment^a

31

Systemic sodium stibogluconate is given when there are big sized lesions^a

32

Systemic sodium stibogluconate is given when lesions are on cosmetically concerned site

33

Response to available CL treatment become evident and significant after two months of treatment^a

34

Infrared therapy of CL lesions is a very good option of treatment either as monotherapy or in combination with other modalities^a

35

Zinc sulfate by mouth could be beneficial if given in combination with traditional therapy to strengthen immunity against CL^a

36

Resistance to treatment in CL is due to the inappropriate way of treatment^a

37

There is a controversy about when to decide systemic sodium stibogluconate for CL treatment. Still, it is not too clear for the physicians the indications for deciding the treatment^a

38

Intralesional metronidazole is effective anti CL treatment^a

39

Presence of resistant species of Leishmania, the emergence of new species or mutation in the previous species are the leading causes of failure of anti-leishmaniasis treatment especially sodium stibogluconate^a

40

Systemic sodium stibogluconate is given when there is no response to intralesional sodium stibogluconate^a